ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Our approach to monitoring response to treatment and adverse effects of therapy for osteomyelitis in children and adolescents

Our approach to monitoring response to treatment and adverse effects of therapy for osteomyelitis in children and adolescents
  When to perform Comments
Clinical evaluation:
  • Temperature
  • Pain and range of movement
  • Localized swelling or erythema
  • At least daily during admission
  • Every 1 to 2 weeks after discharge
  • Worsening or failure to improve may indicate:
    • Development of a complication
    • Unusual or resistant pathogen
    • Polymicrobial infection
    • Inadequate dose of antimicrobial agent, or failure to administer it
    • A diagnosis other than osteomyelitis
CRP and ESR
  • CRP: During admission:
    • Every 2 to 3 days until ≥50% reduction or steady decline has occurred, then weekly if child remains hospitalized
    • If clinical status worsens
    • Weekly during outpatient follow-up
  • ESR: On admission and before stopping antimicrobial therapy*
  • Highly elevated CRP after ≥4 days of treatment may be associated with prolonged symptoms of progression of radiographic changes
  • ESR is usually at its highest 2 to 3 days after beginning antimicrobial therapy and declines slowly
  • We continue antibiotic therapy for 4 weeks or until CRP and ESR are normal, whichever is longer*
CBC with differential
  • Before switch to oral therapy if WBC count is elevated at time of diagnosis
  • The WBC count is elevated at diagnosis in approximately one-third of children with osteomyelitis
  • It usually normalizes within 7 to 10 days of initiation of effective antimicrobial therapy
  • Weekly in children receiving beta-lactam antibiotics (eg, penicillins, cephalosporins)
  • Weekly for in children receiving linezolid for >2 weeks
  • Adverse effects of beta-lactam drugs and linezolid include pancytopenia and leukopenia
Serum antibiotic concentrationsΔ
  • May be useful if poor absorption of antibiotic or failure to administer it are suspected
  • Rare patients have inadequate serum concentrations despite high doses of antimicrobials
Biochemical profile (including serum aminotransferases)
  • Weekly if the patient is receiving penicillin antibiotics or intravenous cephalosporins
  • Adverse effects of beta-lactam drugs include impaired liver or renal function, and antibiotic-associated diarrhea
Radiographs
  • If the clinical status worsens or fails to improve
  • To assess complications:
    • Soft tissue, subperiosteal, or intramedullary abscess
    • Sinus tract
    • Sequestra
    • Pathologic fracture
  • Additional imaging, usually with MRI, may be necessary
  • Before discontinuation of antimicrobial therapy
  • To ensure that there are no new bone lesions (eg, devitalized bone, lytic lesions)
CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; CBC: complete blood count; WBC: white blood cell; MRI: magnetic resonance imaging; MRSA: methicillin-resistant Staphylococcus aureus.
* Some experts do not use normalization of ESR as a criterion for discontinuation of antimicrobial therapy or may document normalization of ESR only in children with osteomyelitis caused by MRSA and in cases that have been initially complicated (eg, concomitant septic arthritis, intraosseous or periosteal abscess or lytic bone lesions at presentation, requiring repeated surgical management of soft tissue foci, delayed normalization of CRP beyond the expected 7 to 10 days).
¶ Some experts also obtain monitoring every 1 to 2 weeks in children receiving clindamycin, although the risk of adverse hematologic effects is lower than with beta-lactam antibiotics.
Δ Expert opinion regarding monitoring of serum antibiotic concentrations varies. Some experts monitor serum concentrations only in children receiving oral therapy in whom CRP (and ESR, if measured) fails to normalize.
Graphic 119278 Version 3.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟